HGH Fragment 176-191 — 25 mg (5 vials × 5 mg)

HGH Fragment 176-191 — targeted lipolytic peptide
5 lyophilised vials × 5 mg (total 25 mg)

• Selective fat-loss: fragment 176-191 increases lipolysis and inhibits lipogenesis without raising blood glucose or IGF-1.
• Reconstitution: add 2 ml bacteriostatic water → 2.5 mg/ml; swirl gently, do not shake.
• Storage: refrigerate 2 – 8 °C after mixing; freeze-dried powder is stable during room-temperature shipping.
• Sample research dosing: 250 – 500 µg sub-Q 1-3 × daily, 30 min pre-cardio, for 4 – 6 weeks.
• QC: ≥ 99 % purity (HPLC); endotoxin < 0.03 EU/mg; scratch-code authenticity on every box.
• Cold-chain packed · tamper-evident vials · discreet, tracked worldwide delivery.